ArticleJournal of hepatocellular carcinoma2025

A Novel Quadruple Conversion Therapy: Converting Initially Unresectable Hepatocellular Carcinoma to Resectable with pTAE-HAIC, Tyrosine Kinase Inhibitors, and Anti-PD-1 Antibodies.

Jing Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.